Registration Dossier

Administrative data

Description of key information

An in vivo study is available for AITC, therefore in vitro/in chemico studies were not performed. Since no EC3 could be calculated, no subcategory 1a or 1B could be assigned. Human studies reported in section 7.10.4 support this classification.Moreover, human data reported in section 7.10.4, indicate that AITC may produce allergy or asthma symptoms or breathing difficulties if inhaled.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vitro
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

According to Regulation (EC) n. 1272/2008, AITC is classified as Skin Sens. 1, H317.